Protective role of metalloproteinase inhibitor (AE-941) on ulcerative colitis in rats

Table 4 Colonic mucosal protein expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 (mean ± SD)

Time	Control group		Model group		AE-941 group
	MMP-2	MMP-9	MMP-2	MMP-9	MMP-2	MMP-9
7th day	0.0053 ± 0.0037	0.0073 ± 0.0015	0.0986 ± 0.0084a	0.0916 ± 0.0077a	0.0923 ± 0.0071	0.0893 ± 0.0075
21st day	0.0047 ± 0.0027	0.0067 ± 0.0011	0.0773 ± 0.0052a	0.0748 ± 0.0067a	0.0536 ± 0.0034c	0.0554 ± 0.0061c
56th day	0.0057 ± 0.0026	0.0070 ± 0.0013	0.0453 ± 0.0036a	0.0537 ± 0.0035a	0.0324 ± 0.0025c	0.0364 ± 0.0025c

^aP < 0.05 vs control group;

^cP < 0.05 vs model group. MMP: Matrix metalloproteinase.